Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. - Warner BM; Vendramelli R; Boese AS; Audet J; Tailor N; Meilleur C; Glowach N; Willman M; Truong T; Moffat E; Tierney K; Kosak B; et al. (PloS one, 2025)